Genix Pharmaceuticals Corp
XTSX:GENX

Watchlist Manager
Genix Pharmaceuticals Corp Logo
Genix Pharmaceuticals Corp
XTSX:GENX
Watchlist
Price: 0.03 CAD 20% Market Closed
Market Cap: 1.8m CAD
Section:
 

Relative Value

GENX doesn't have a meaningful market cap.

The Relative Value of one GENX stock under the Base Case scenario is hidden CAD. Compared to the current market price of 0.03 CAD, Genix Pharmaceuticals Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GENX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

17 767.2
P/S
P/S
Price to Sales
17 767.2
vs History
1
vs Industry
0
Median 3Y
672.8
Median 5Y
219.4
Industry
1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-3.9
Median 5Y
-5.5
Industry
17.7
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-14
Median 5Y
-17.5
Industry
11.7
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
0
Median 3Y
-120.3
Median 5Y
-34.3
Industry
15.6
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
59
Median 3Y
-1.5
Median 5Y
1.2
Industry
1.5
More Details
27 950.2
EV/S
EV/S
Enterprise Value to Sales
27 950.2
vs History
1
vs Industry
0
Median 3Y
830
Median 5Y
271.8
Industry
1.2
More Details
Negative
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
0
Median 3Y
1 216.5
Median 5Y
-2 795
Industry
4
More Details
38.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
38.7
vs History
11
vs Industry
Median 3Y
-1.3
Median 5Y
-8.6
Industry
10.4
More Details
39.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
39.3
vs History
11
vs Industry
Median 3Y
-1.2
Median 5Y
-4.2
Industry
13.5
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-19.6
Median 5Y
-20.7
Industry
12.5
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-19.4
Median 5Y
-20.1
Industry
15.6
More Details
Negative
EV/IC
EV/IC
Enterprise Value to IC
N/A
vs History
vs Industry
48
Median 3Y
-23.4
Median 5Y
1
Industry
1.2
More Details

Multiples Across Competitors

GENX Competitors Multiples
Genix Pharmaceuticals Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Genix Pharmaceuticals Corp
XTSX:GENX
1.8m CAD 17 767.2 -20 38.7 39.3
FR
L'Oreal SA
PAR:OR
195.4B EUR 4.5 31.9 18.5 22.6
UK
Unilever PLC
LSE:ULVR
119.1B GBP 2.2 23.8 185.3 215.3
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.4T INR 8.5 50 36.2 40.1
UK
HALEON PLC
LSE:HLN
33.7B GBP 3 23.4 14.1 16
US
Estee Lauder Companies Inc
NYSE:EL
37.7B USD 2.6 -40.6 20.6 34
MY
Nova Wellness Group Bhd
KLSE:NOVAMSC
127.8B MYR 2 793.4 -12 944.3 43 546.1 -16 394.1
DE
Beiersdorf AG
XETRA:BEI
20.6B EUR 2.1 23.4 11.5 14.7
JP
Kao Corp
TSE:4452
2.9T JPY 1.7 23.6 11.2 17.3
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR 8.4 68.6 42.6 46.7
IN
Dabur India Ltd
NSE:DABUR
892.5B INR 7 49.3 37 45.8
P/E Multiple
Earnings Growth PEG
CA
Genix Pharmaceuticals Corp
XTSX:GENX
Average P/E: 36.8
Negative Multiple: -20 		N/A N/A
FR
L'Oreal SA
PAR:OR
31.9
8%
4
UK
Unilever PLC
LSE:ULVR
23.8
15%
1.6
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
50
8%
6.2
UK
HALEON PLC
LSE:HLN
23.4
12%
1.9
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -40.6 N/A N/A
MY
N
Nova Wellness Group Bhd
KLSE:NOVAMSC
Negative Multiple: -12 944.3 N/A N/A
DE
Beiersdorf AG
XETRA:BEI
23.4
8%
2.9
JP
Kao Corp
TSE:4452
23.6
13%
1.8
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
68.6
19%
3.6
IN
Dabur India Ltd
NSE:DABUR
49.3
12%
4.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Genix Pharmaceuticals Corp
XTSX:GENX
Average EV/EBITDA: 3 996.5
38.7
N/A N/A
FR
L'Oreal SA
PAR:OR
18.5
5%
3.7
UK
Unilever PLC
LSE:ULVR
185.3
1%
185.3
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
36.2
8%
4.5
UK
HALEON PLC
LSE:HLN
14.1
4%
3.5
US
Estee Lauder Companies Inc
NYSE:EL
20.6
15%
1.4
MY
N
Nova Wellness Group Bhd
KLSE:NOVAMSC
43 546.1
N/A N/A
DE
Beiersdorf AG
XETRA:BEI
11.5
-1%
N/A
JP
Kao Corp
TSE:4452
11.2
8%
1.4
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
42.6
13%
3.3
IN
Dabur India Ltd
NSE:DABUR
37
11%
3.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Genix Pharmaceuticals Corp
XTSX:GENX
Average EV/EBIT: 49.2
39.3
N/A N/A
FR
L'Oreal SA
PAR:OR
22.6
6%
3.8
UK
Unilever PLC
LSE:ULVR
215.3
1%
215.3
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
40.1
9%
4.5
UK
HALEON PLC
LSE:HLN
16
4%
4
US
Estee Lauder Companies Inc
NYSE:EL
34
25%
1.4
MY
N
Nova Wellness Group Bhd
KLSE:NOVAMSC
Negative Multiple: -16 394.1 N/A N/A
DE
Beiersdorf AG
XETRA:BEI
14.7
-2%
N/A
JP
Kao Corp
TSE:4452
17.3
N/A N/A
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
46.7
13%
3.6
IN
Dabur India Ltd
NSE:DABUR
45.8
11%
4.2

See Also

Summary
GENX intrinsic value, competitors valuation, and company profile.
DCF Valuation
GENX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GENX stock valuation using valuation multiples.
Wall Street Estimates
GENX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GENX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 306,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.